New test may help to ensure that dengue vaccines do no harm

As vaccines against a virus that infects 100 million people annually reach late-stage clinical trials this year, researchers have developed a test to better predict whether a given vaccine candidate should protect patients from the infection, or in some cases, make it more dangerous, according to an article just published in the journal Clinical and Vaccine Immunology.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news153669699.html">New test may help to ensure that dengue vaccines do no harm</a></p> <p>As vaccines against a virus that infects 100 million people annually reach late-stage clinical trials this year, researchers have developed a test to better predict whether a given vaccine candidate should protect patients from the infection, or in some cases, make it more dangerous, according to an article just published in the journal <I>Clinical and Vaccine Immunology</I>.</p>